Management of toxic optic neuropathy via a combination of Wharton’s jelly-derived mesenchymal stem cells with electromagnetic stimulation

Overview of attention for article published in Stem Cell Research & Therapy, September 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 19 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 3 publications that cite this research output.

3

The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.

Preconditioning of Mesenchymal Stem Cells with Electromagnetic Fields and Its Impact on Biological Responses and “Fate”—Potential Use in Therapeutic Applications

Article in Frontiers in Bioscience-Landmark (November 2023)

Management of Retinitis Pigmentosa Via Wharton’s Jelly-Derived Mesenchymal Stem Cells or Combination With Magnovision: 3-Year Prospective Results

Article in Stem Cells Translational Medicine (September 2023)

The potential for mitochondrial therapeutics in the treatment of primary open-angle glaucoma: a review

Article in Frontiers in Physiology (August 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.